Reverse mutants of the catalytic 19 kda mutant protein (nanokaz/nanoluc) from oplophorus luciferase with coelenterazine as preferred substrate

HIGHLIGHTS

• who: Satoshi Inouye and collaborators from the Bioscience, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda-ku, Tokyo, Japan have published the research: Reverse mutants of the catalytic 19 kDa mutant protein (nanoKAZ/nanoLuc) from Oplophorus luciferase with coelenterazine as preferred substrate, in the Journal: PLOS ONE of 18/05/2022
• what: Result, the authors focused on the amino-terminal region of wild KAZ (wK: 1-82 aa) and produced three reverse mutants of nK-AQQL (E4A, R11Q, L18Q, and V27L), nK-KVA (R43K, I44V, and I54A), and nK-FLM (D68F . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.